Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12

  • Bahareh Farasati Far
  • , Dmitry Bokov
  • , Gunawan Widjaja
  • , Hendrik Setia Budi
  • , Walid Kamal Abdelbasset
  • , Shahrzad Javanshir
  • , Farhad Seif
  • , Hamidreza Pazoki-Toroudi
  • , Sanjay Kumar Dey

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science